September

Improved survival albeit with persistent disparities in prognosis for people with cystic fibrosis in European countries Clémence Martin, Pierre-Régis Burgel Eur Respir J, 58 (3) 2101487; 10.1183/13993003.01487-2021
Oxygen therapy target ranges: finding the balance Christiaan Yu, Belinda R. Miller Eur Respir J, 58 (3) 2101023; 10.1183/13993003.01023-2021
COVID-19 pneumonia and the pulmonary vasculature: a marriage made in hell Peter M. George, Sujal R. Desai Eur Respir J, 58 (3) 2100811; 10.1183/13993003.00811-2021
NOVELTY: a landmark study in phenotyping and endotyping chronic obstructive airway diseases in real clinical practice Renaud Louis, Gilles Louis, Olivier Bonhomme Eur Respir J, 58 (3) 2100627; 10.1183/13993003.00627-2021
Omega-3 polyunsaturated fatty acids and FADS genotype: is personalised prevention of asthma on the horizon? Vanessa Garcia-Larsen Eur Respir J, 58 (3) 2101386; 10.1183/13993003.01386-2021
Harnessing the power of anticipation to manage respiratory-related brain suffering and ensuing dyspnoea: insights from the neurobiology of the respiratory nocebo effect Fabien Vinckier, Sophie Betka, Nathalie Nion, Laure Serresse, Thomas Similowski Eur Respir J, 58 (3) 2101876; 10.1183/13993003.01876-2021
Dyspnoea upon hospital admission: listen to the bird of ill omen! Maxens Decavèle, Thomas Similowski Eur Respir J, 58 (3) 2100988; 10.1183/13993003.00988-2021
Recommendations for respiratory syncytial virus surveillance at the national level Anne C. Teirlinck, Eeva K. Broberg, Are Stuwitz Berg, Harry Campbell, Rachel M. Reeves, AnnaSara Carnahan, Bruno Lina, Gatis Pakarna, Håkon Bøås, Hanna Nohynek, Hanne-Dorthe Emborg, Harish Nair, Janine Reiche, Jesus Angel Oliva, Joanne O’Gorman, John Paget, Karol Szymanski, Kostas Danis, Maja Socan, Manuel Gijon, Marie Rapp, Martina Havlíc?ková, Ramona Trebbien, Raquel Guiomar, Siddhivinayak S. Hirve, Silke Buda, Sylvie van der Werf, Adam Meijer, Thea K. Fischer Eur Respir J, 58 (3) 2003766; 10.1183/13993003.03766-2020
Survival estimates in European cystic fibrosis patients and the impact of socioeconomic factors: a retrospective registry cohort study Edward F. McKone, Cono Ariti, Abaigeal Jackson, Anna Zolin, Siobhán B. Carr, Annalisa Orenti, Jacqui G. van Rens, Lydie Lemonnier, Milan Macek, Ruth H. Keogh, Lutz Naehrlich Eur Respir J, 58 (3) 2002288; 10.1183/13993003.02288-2020
Classification and effectiveness of different oxygenation goals in mechanically ventilated critically ill patients: network meta-analysis of randomised controlled trials Xu Zhao, Huaping Xiao, Feng Dai, Daniel Brodie, Lingzhong Meng Eur Respir J, 58 (3) 2002928; 10.1183/13993003.02928-2020
“You can leave your mask on”: effects on cardiopulmonary parameters of different airway protective masks at rest and during maximal exercise Massimo Mapelli, Elisabetta Salvioni, Fabiana De Martino, Irene Mattavelli, Paola Gugliandolo, Carlo Vignati, Stefania Farina, Pietro Palermo, Jeness Campodonico, Riccardo Maragna, Gerardo Lo Russo, Alice Bonomi, Susanna Sciomer, Piergiuseppe Agostoni Eur Respir J, 58 (3) 2004473; 10.1183/13993003.04473-2020
Medium-term impact of COVID-19 on pulmonary function, functional capacity and quality of life Fabio Anastasio, Sarah Barbuto, Elisa Scarnecchia, Paolo Cosma, Alessandro Fugagnoli, Giulio Rossi, Mirco Parravicini, Pierpaolo Parravicini Eur Respir J, 58 (3) 2004015; 10.1183/13993003.04015-2020
Altered pulmonary blood volume distribution as a biomarker for predicting outcomes in COVID-19 disease Michael F. Morris, Yash Pershad, Paul Kang, Lauren Ridenour, Ben Lavon, Maarten Lanclus, Rik Godon, Jan De Backer, Marilyn K. Glassberg Eur Respir J, 58 (3) 2004133; 10.1183/13993003.04133-2020
Maternal 17q21 genotype influences prenatal vitamin D effects on offspring asthma/recurrent wheeze Hanna M. Knihtilä, Rachel S. Kelly, Nicklas Brustad, Mengna Huang, Priyadarshini Kachroo, Bo L. Chawes, Jakob Stokholm, Klaus Bønnelykke, Casper-Emil T. Pedersen, Hans Bisgaard, Augusto A. Litonjua, Jessica A. Lasky-Su, Scott T. Weiss Eur Respir J, 58 (3) 2002012; 10.1183/13993003.02012-2020
Triple therapy in uncontrolled asthma: a network meta-analysis of phase III studies Paola Rogliani, Beatrice Ludovica Ritondo, Luigino Calzetta Eur Respir J, 58 (3) 2004233; 10.1183/13993003.04233-2020
Heterogeneity within and between physician-diagnosed asthma and/or COPD: NOVELTY cohort Helen K. Reddel, Jørgen Vestbo, Alvar Agustí, Gary P. Anderson, Aruna T. Bansal, Richard Beasley, Elisabeth H. Bel, Christer Janson, Barry Make, Ian D. Pavord, David Price, Eleni Rapsomaniki, Niklas Karlsson, Donna K. Finch, Javier Nuevo, Alex de Giorgio-Miller, Marianna Alacqua, Rod Hughes, Hana Müllerová, Maria Gerhardsson de Verdier Eur Respir J, 58 (3) 2003927; 10.1183/13993003.03927-2020
Intake of n-3 polyunsaturated fatty acids in childhood, FADS genotype and incident asthma Mohammad Talaei, Emmanouela Sdona, Philip C. Calder, Louise R. Jones, Pauline M. Emmett, Raquel Granell, Anna Bergström, Erik Melén, Seif O. Shaheen Eur Respir J, 58 (3) 2003633; 10.1183/13993003.03633-2020
Expectation and dyspnoea: the neurobiological basis of respiratory nocebo effects Elke Vlemincx, Christian Sprenger, Christian Büchel Eur Respir J, 58 (3) 2003008; 10.1183/13993003.03008-2020
Association of dyspnoea, mortality and resource use in hospitalised patients Jennifer P. Stevens, Tenzin Dechen, Richard M. Schwartzstein, Carl R. O'Donnell, Kathy Baker, Robert B. Banzett Eur Respir J, 58 (3) 1902107; 10.1183/13993003.02107-2019
Combining pulmonary and cardiac computed tomography biomarkers for disease-specific risk modelling in lung cancer screening Anton Schreuder, Colin Jacobs, Nikolas Lessmann, Mireille J.M. Broeders, Mario Silva, Ivana Išgum, Pim A. de Jong, Nicola Sverzellati, Mathias Prokop, Ugo Pastorino, Cornelia M. Schaefer-Prokop, Bram van Ginneken Eur Respir J, 58 (3) 2003386; 10.1183/13993003.03386-2020
Prediction of anti-tuberculosis treatment duration based on a 22-gene transcriptomic model Jan Heyckendorf, Sebastian Marwitz, Maja Reimann, Korkut Avsar, Andrew R. DiNardo, Gunar Günther, Michael Hoelscher, Elmira Ibraim, Barbara Kalsdorf, Stefan H.E. Kaufmann, Irina Kontsevaya, Frank van Leth, Anna M. Mandalakas, Florian P. Maurer, Marius Müller, Dörte Nitschkowski, Ioana D. Olaru, Cristina Popa, Andrea Rachow, Thierry Rolling, Jan Rybniker, Helmut J.F. Salzer, Patricia Sanchez-Carballo, Maren Schuhmann, Dagmar Schaub, Victor Spinu, Isabelle Suárez, Elena Terhalle, Markus Unnewehr, January Weiner, Torsten Goldmann, Christoph Lange Eur Respir J, 58 (3) 2003492; 10.1183/13993003.03492-2020
The pathophysiological role of novel pulmonary arterial hypertension gene SOX17 Yukyee Wu, John Wharton, Rachel Walters, Eleni Vasilaki, Jurjan Aman, Lan Zhao, Martin R. Wilkins, Christopher J. Rhodes Eur Respir J, 58 (3) 2004172; 10.1183/13993003.04172-2020
Endothelial cells in the pathogenesis of pulmonary arterial hypertension Colin E. Evans, Nicholas D. Cober, Zhiyu Dai, Duncan J. Stewart, You-Yang Zhao Eur Respir J, 58 (3) 2003957; 10.1183/13993003.03957-2020
Availability of fixed-dose, child-friendly formulations of first-line tuberculosis drugs in Europe Antoni Noguera-Julian, Danilo Buonsenso, Lindsay McKenna, James A. Seddon, Nicole Ritz Eur Respir J, 58 (3) 2101196; 10.1183/13993003.01196-2021
A single blood eosinophil count measurement is as good as two for prediction of ICS treatment response in the IMPACT trial Mona Bafadhel, Neil Barnes, Stephen C. Bourke, Chris Compton, Gerard J. Criner, Mark T. Dransfield, David M.G. Halpin, MeiLan K. Han, Benjamin Hartley, C. Elaine Jones, Peter Lange, Sally Lettis, David A. Lipson, David A. Lomas, Neil Martin, Fernando J. Martinez, Robert Wise, Dave Singh Eur Respir J, 58 (3) 2004522; 10.1183/13993003.04522-2020
Five-year survival after an acute episode of decompensated pulmonary arterial hypertension in the modern management era of right heart failure Laurent Savale, Constance Vuillard, Jérémie Pichon, Athénaïs Boucly, Anne Roche, Mitja Jevnikar, Nathan Ebstein, Xavier Jaïs, Jérôme Le Pavec, David Montani, Olaf Mercier, Olivier Sitbon, Elie Fadel, Marc Humbert Eur Respir J, 58 (3) 2100466; 10.1183/13993003.00466-2021
COVID-19 pneumothorax in the UK: a prospective observational study using the ISARIC WHO clinical characterisation protocol Stefan J. Marciniak, James Farrell, Anthony Rostron, Ian Smith, Peter J.M. Openshaw, J. Kenneth Baillie, Annemarie Docherty, Malcolm G. Semple Eur Respir J, 58 (3) 2100929; 10.1183/13993003.00929-2021
Outbreak of pre- and extensively drug-resistant tuberculosis in northern Italy: urgency of cross-border, multidimensional, surveillance systems Simone Villa, Elisa Tagliani, Emanuele Borroni, Paola Francesca Castellotti, Maurizio Ferrarese, Arash Ghodousi, Anna Lamberti, Sabrina Senatore, Marino Faccini, Daniela Maria Cirillo, Luigi Ruffo Codecasa Eur Respir J, 58 (3) 2100839; 10.1183/13993003.00839-2021
Mycobacterium tuberculosis borderline rpoB mutations: emerging from the unknown Armand Van Deun, Tom Decroo, Kya Jai Maug Aung, Mohamed Anwar Hossain, Mourad Gumusboga, Willem Bram De Rijk, Sabira Tahseen, Bouke Catherine de Jong, Leen Rigouts Eur Respir J, 58 (3) 2100783; 10.1183/13993003.00783-2021
Protective face masks add significant dead space Christoph Elbl, Josef X. Brunner, Dominic Schier, Adrian Junge, Helge Junge Eur Respir J, 58 (3) 2101131; 10.1183/13993003.01131-2021
When adopting Global Lung Function Initiative reference values, can we also adapt them to a local context as needed? Sylvia Verbanck, Eef Vanderhelst, Shane Hanon Eur Respir J, 58 (3) 2101601; 10.1183/13993003.01601-2021
Reply to: When adopting Global Lung Function Initiative reference values, can we also adapt them to a local context as needed? Sanja Stanojevic, Brendan Cooper, Nicole Filipow, Jane Kirkby, Gregg Ruppel, Irene Steenbruggen, Bruce Thompson, Graham Hall Eur Respir J, 58 (3) 2102020; 10.1183/13993003.02020-2021
When biology meets behaviour: can medication adherence mask the contribution of pharmacogenetic effects in asthma? Job F.M. van Boven, Boudewijn J.H. Dierick, Omar S. Usmani Eur Respir J, 58 (3) 2100304; 10.1183/13993003.00304-2021
Considerations of a real life pragmatic clinical trial in adolescent asthma Tom Ruffles, Brian Lipworth, Somnath Mukhopadhyay Eur Respir J, 58 (3) 2100461; 10.1183/13993003.00461-2021
miR-184 mediates hyperoxia-induced injury by targeting cell death and angiogenesis signalling pathways in the developing lung Dilip Shah, Karmyodh Sandhu, Pragnya Das, Zubair H. Aghai, Sture Andersson, Gloria Pryhuber, Vineet Bhandari Eur Respir J, 58 (3) 1901789; 10.1183/13993003.01789-2019